71 related articles for article (PubMed ID: 30421573)
1. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
2. Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms.
Ronco G; Zappa M; Franceschi S; Tunesi S; Caprioglio A; Confortini M; Del Mistro A; Carozzi F; Segnan N; Zorzi M; Giorgi-Rossi P;
Eur J Cancer; 2016 Nov; 68():148-155. PubMed ID: 27755998
[TBL] [Abstract][Full Text] [Related]
3. HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.
Rijkaart DC; Berkhof J; van Kemenade FJ; Coupe VM; Rozendaal L; Heideman DA; Verheijen RH; Bulk S; Verweij W; Snijders PJ; Meijer CJ
Br J Cancer; 2012 Feb; 106(5):975-81. PubMed ID: 22251922
[TBL] [Abstract][Full Text] [Related]
4. Triage of Women Testing Positive With the careHPV Test on Self-Collected Vaginal Samples for Cervical Cancer Screening in a Low-Resource Setting.
Poli UR; Gowrishankar S; Swain M; Jeronimo J
J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241206
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort.
Rodríguez AC; Ávila C; Herrero R; Hildesheim A; Sherman ME; Burk RD; Morales J; Alfaro M; Guillén D; Trejos ME; Vargas RM; Torres G; Schiffman M
Int J Cancer; 2017 Apr; 140(8):1926-1934. PubMed ID: 28120391
[TBL] [Abstract][Full Text] [Related]
6. Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study.
Del Mistro A; Giorgi Rossi P; Frayle H; Pasquale L; Campari C; Ronco G; Zorzi M
BJOG; 2019 Oct; 126(11):1365-1371. PubMed ID: 31356722
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.
van Rosmalen J; de Kok IM; van Ballegooijen M
BJOG; 2012 May; 119(6):699-709. PubMed ID: 22251259
[TBL] [Abstract][Full Text] [Related]
8. Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.
Stoler MH; Austin RM; Zhao C
J Clin Microbiol; 2015 Sep; 53(9):2798-804. PubMed ID: 25948606
[TBL] [Abstract][Full Text] [Related]
9. The impact of loss to follow-up in the Dutch organised HPV-based cervical cancer screening programme.
Olthof EMG; Aitken CA; Siebers AG; van Kemenade FJ; de Kok IMCM
Int J Cancer; 2024 Jun; 154(12):2132-2141. PubMed ID: 38436201
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India.
Basu P; Mittal S; Banerjee D; Singh P; Panda C; Dutta S; Mandal R; Das P; Biswas J; Muwonge R; Sankaranarayanan R
Int J Cancer; 2015 Aug; 137(4):859-67. PubMed ID: 25631198
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a compact, rechargeable, magnifying device to triage VIA and HPV positive women in a cervical cancer screening program in rural India.
Basu P; Banerjee D; Mittal S; Mandal R; Ghosh I; Das P; Muwonge R; Biswas J
Cancer Causes Control; 2016 Oct; 27(10):1253-9. PubMed ID: 27581249
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the performance of algorithms for cervical cancer screening: evidence from the Ludwig-McGill cohort study.
Chevarie-Davis M; Ramanakumar AV; Ferenczy A; Villa LL; Franco EL;
Gynecol Oncol; 2013 Mar; 128(3):415-9. PubMed ID: 23234804
[TBL] [Abstract][Full Text] [Related]
13. Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.
Silver MI; Rositch AF; Phelan-Emrick DF; Gravitt PE
Cancer Causes Control; 2018 Jan; 29(1):43-50. PubMed ID: 29124542
[TBL] [Abstract][Full Text] [Related]
14. HPV-based cervical cancer screening in Nicaragua: from testing to treatment.
Holme F; Maldonado F; Martinez-Granera OB; Rodriguez JM; Almendarez J; Slavkovsky R; Bansil P; Thomson KA; Jeronimo J; de Sanjose S
BMC Public Health; 2020 Apr; 20(1):495. PubMed ID: 32295562
[TBL] [Abstract][Full Text] [Related]
15. Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly.
Rebolj M; Sargent A; Njor SH; Cuschieri K
Int J Cancer; 2023 Jul; 153(1):8-19. PubMed ID: 36385698
[TBL] [Abstract][Full Text] [Related]
16. HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs.
Campari C; Fedato C; Petrelli A; Zorzi M; Cogo C; Caprioglio A; Gallo F; Giordano L; Domenighini S; Pasquale L; Prandi S; Zappa M; Giorgi Rossi P;
Infect Agent Cancer; 2015; 10():14. PubMed ID: 25969693
[TBL] [Abstract][Full Text] [Related]
17. Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.
Ogilvie GS; Smith LW; van Niekerk DJ; Khurshed F; Krajden M; Saraiya M; Goel V; Rimer BK; Greene SB; Hobbs S; Coldman AJ; Franco EL
Int J Cancer; 2013 Dec; 133(12):2934-43. PubMed ID: 23754203
[TBL] [Abstract][Full Text] [Related]
18. The performance of single and combination test strategies using visual inspection, cytology, high-risk HPV DNA and HPV16/18 to screen South African women with and without HIV-infection.
Dreyer G; Visser C; Dreyer GJ; Botha MH; van der Merwe FH; Richter KL; Snyman LC
Infect Agent Cancer; 2024 May; 19(1):22. PubMed ID: 38725062
[TBL] [Abstract][Full Text] [Related]
19. Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study.
Hill E; Nemec M; Marlow L; Sherman SM; Waller J
J Med Screen; 2021 Sep; 28(3):333-340. PubMed ID: 33175638
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening program in Thimphu, Bhutan: population coverage and characteristics associated with screening attendance.
Baussano I; Tshomo U; Clifford GM; Tenet V; Tshokey T; Franceschi S
BMC Womens Health; 2014 Nov; 14():147. PubMed ID: 25433538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
